43 results about "Justicia gendarussa" patented technology

The invention discloses a vulnerary hemostatic and a preparation process thereof. The vulnerary hemostatic comprises the raw Chinese medicinal herbs as main medicaments by weight: 20-40 parts of baeckea frutescens, 10-30 parts of big-leaf beautyberry leaf, 10- 30 parts of ageratum conyzoides, 10-30 parts of hairyvein agrimony, 10-30 parts of teucrium viscidum, and 10-30 parts of herba cirsii japonica, which are mainly used for stopping bleeding and relieving pain; straw, red psychotria leaf, false China tree and lemon-scented gum leaf capable of diminishing inflammation and promoting tissue regeneration can be used as auxiliary medicaments; adhatoda ventricosa, common gendarussa herb and glechoma biondiana with the functions of removing blood stasis, promoting tissue regeneration and promoting blood circulation to remove meridian obstruction are used as assistant; and through reasonable combination, the pharmacological functions of stopping bleeding, relieving pain, diminishing inflammation, removing blood stasis, promoting tissue regeneration and promoting blood circulation to remove meridian obstruction are realized, and the aims of quickly treating wound and stopping bleeding are fulfilled. According to the vulnerary hemostatic preparation process, the finished product is prepared by the processes of crushing, sieving, drying, stirring and the like; and the original effects of the medicaments are preserved, the properties of the medicaments are not affected because the medicaments are not chemically processed, and the obtained finished product has a stable treatment effect. The vulnerary hemostatic has the characteristics of high hemostatic speed, low cost, good effects of diminishing inflammation, relieving pain and promoting tissue regeneration, no toxic or side effect, convenience in use, convenience in collection of raw medicinal herbs and easiness for popularization and application.

The invention relates to a pharmaceutical composition of treating prostatitis. The pharmaceutical composition is prepared from the following substances by weigh ratio: perfoliote knotweed herb, radix pseudostellariae, fructus broussonetiae, Chinese mahonia stem, manchurian lilac bark, bighead atractylodes rhizome, medulla helwingiae, pseudo-ginseng, witloof, gastrodia elata, thlaspi arvense, dioscorea spongiosa, pinellia ternate, loofah sponge, concha arcae, justicia gendarussa, arisaema cum bile, reddish orange, immature bitter orange, hooker winghead root, tuckahoe, seed of feather cockscomb, liquorice, rhizoma nelumbinis, herba siegesbeckiae, ginger, white lablab bean, semen coicis, semen coicis, chinaroot greenbrier, radix angelicae, sauropus spatulifolius, cortex dictamni, angelica sinensis, ligusticum wallichii, piper cubeba, root of common peony, peach kernel, spina date seed, peucedanum decursivum maxim and kapok. The pharmaceutical composition for treating prostatitis disclosed by the invention has the characteristics of being low in cost, easy to prepare, small in toxic and side effects, significant in curative effect.

Provided herein are glycosylarylnaphthalenoid lignan compounds, such as jupecumin A, isolated from the plant Justicia gendarussa Burm.f. (Acanthaceae) effective in the treatment of AIDS and HIV infection (justiprocumin A).